文献速递主动脉外科

风险建模优化降主动脉胸段动脉瘤治疗的患者选择

Risk Modeling to Optimize Patient Selection for Management of the Descending Thoracic Aortic Aneurysm.
PubMed 文献 · Ann Thorac Surg · 2017-12-21

单中心研究比较2005至2014年438例降主动脉胸段动脉瘤患者(TEVAR 88例,开放手术350例)的早期与长期结局。TEVAR组透析、呼吸衰竭和ICU住院时间更低,早期死亡率在特定高危亚组中更低;倾向评分校正后开放手术、目标人群、糖尿病、外周血管病和急诊状态是早期死亡的预测因素。作者认为在合并显著合并症的老年患者中TEVAR可能更优。

要点

  • TEVAR组透析3% vs 开放手术18%(p<0.001),呼吸衰竭10% vs 34%(p<0.001),ICU住院2.0 vs 5.0天(p<0.001)。
  • 早期死亡率TEVAR 6% vs 开放手术12%(p=0.121),差异无统计学显著。
  • 倾向评分校正后开放手术OR 4.3(p<0.024)与目标人群OR 7.7(p<0.001)为早期死亡预测因素。

核心结论

  • 在合并显著合并症的老年患者中,TEVAR较开放手术显示出更优的结果,作者认为在该目标人群中TEVAR可能更可取。

研究设计与样本

  • 单中心研究,2005年至2014年共治疗438例降主动脉胸段动脉瘤患者,其中TEVAR 88例、开放手术350例,排除急性夹层与创伤性损伤。
  • 回顾围手术期与随访数据,进行分层分析以识别最可能从TEVAR获益的患者,并通过逻辑回归建立TEVAR倾向评分,死亡预测的逻辑回归与Cox回归模型均对倾向评分进行校正。

主要发现

  • TEVAR组患者多为老年女性,且急诊状态、慢性阻塞性肺疾病或冠心病更常见。
  • TEVAR组与开放手术组的即期运动缺陷(0% vs 1%,p=0.588)、迟发运动缺陷(5% vs 6%,p=1.000)及早期死亡率(6% vs 12%,p=0.121)相似。
  • TEVAR组透析(3% vs 18%,p<0.001)、呼吸衰竭(10% vs 34%,p<0.001)及ICU住院时间(2.0 vs 5.0天,p<0.001)均低于开放手术组。
  • TEVAR组早期死亡率在七十余岁患者(3% vs 16%,p<0.02)、肾小球滤过率低于60 mL/min者(8% vs 32%,p<0.049)、慢性阻塞性肺疾病者(6% vs 21%,p<0.02)中更低;目标人群定义为归因于TEVAR的死亡率降低四倍(p<0.006)。
  • 倾向评分校正后早期死亡预测因素包括开放手术(OR 4.3,p<0.024)、目标人群(OR 7.7,p<0.001)、糖尿病(OR 3,p<0.009)、外周血管病(OR 4.7,p<0.001)及急诊状态(OR 4.6,p<0.001);生存的决定因素为年龄、肾小球滤过率低于60 mL/min、外周血管病、慢性阻塞性肺疾病及急诊状态。

临床怎么用

  • 作者认为,在合并显著合并症的老年患者中,TEVAR可能更可取。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A single-institutional study comparing early and long-term outcomes of thoracic endovascular aortic repair (TEVAR) and open surgical repair (OSR) was performed to determine the appropriate treatment option for descending thoracic aortic aneurysm (DTAA). METHODS: Between 2005 and 2014, 438 DTAA patients were treated (TEVAR, 88; OSR, 350). Acute dissection and traumatic injury were excluded. Perioperative and follow-up data were reviewed. Stratified analyses were conducted to identify patients most likely to benefit from TEVAR. A propensity score for TEVAR was developed by logistic regression, and predictive logistic and Cox regression models for death were adjusted for propensity score. RESULTS: TEVAR patients were frequently older women with emergent status, chronic obstructive pulmonary disease, or coronary artery disease. TEVAR had similar immediate (0% vs 1%; p = 0.588) and delayed (5% vs 6%, p = 1.000) motor deficits and early mortality (6% vs 12%, p = 0.121) but lower dialysis (3% vs 18%, p < 0.001), respiratory failure (10% vs 34%, p < 0.001), and intensive care unit stay (2.0 vs 5.0 days, p < 0.001). Early mortality after TEVAR was lower in septuagenarians (3% vs 16%, p < 0.02), glomerular filtration rate of less than 60 mL/min (8% vs 32%, p < 0.049), chronic obstructive pulmonary disease (6% vs 21%, p < 0.02), defined as target population that had fourfold mortality reduction (p < 0.006) attributable to TEVAR. Propensity-adjusted predictors of early mortality predictors included OSR (odds ratio [OR], 4.3; p < 0.024), target population (OR, 7.7; p < 0.001), diabetes (OR, 3; p < 0.009), peripheral vascular disease (OR, 4.7; p < 0.001), and emergent status (OR, 4.6; p < 0.001). Propensity-adjusted determinants of survival were age, glomerular filtration rate of less than 60 mL/min, peripheral vascular disease, chronic obstructive pulmonary disease, and emergent status. CONCLUSIONS: In older patients with significant comorbidities, TEVAR demonstrated superior results compared with OSR and may be preferable in this target population.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Tanaka A, Sandhu HK, Pratt WB, et al. Risk Modeling to Optimize Patient Selection for Management of the Descending Thoracic Aortic Aneurysm. Ann Thorac Surg. 2017. PMID: 29275829. doi:10.1016/j.athoracsur.2017.09.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。